- it ensures the use of joint marker panels, which will cut genotyping costs
- it centralizes the bioinformatic and transcript knowledge for a certain chomosomal region
- It facilitates the cross-phenotyping approach (i. E. different inflammatory disorders with overlapping risk mutations)
The respective scientists for the subprojects that choose to be organised in this way, will be directly anchored and employed on the respective centralized molecular high-throughput platforms of each site.